357
Views
1
CrossRef citations to date
0
Altmetric
Review

Prevention of pancreatitis after stent implantation for distal malignant biliary strictures: systematic review and meta-analysis

, , &
Pages 141-154 | Received 19 Jul 2021, Accepted 06 Jan 2022, Published online: 21 Jan 2022

References

  • Sunpaweravong S, Ovartlarnporn B, Khow-ean U, et al. Endoscopic stenting versus surgical bypass in advanced malignant distal bile duct obstruction: cost-effectiveness analysis. Asian J Surg. 2005;28(4):262–265.
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
  • Chu D, Adler DG. Malignant biliary tract obstruction: evaluation and therapy. J Natl Compr Canc Netw. 2010;8(9):1033–1044.
  • Lokich BJJ, Kane RA, Harrison DA, et al. Biliary tract obstruction secondary to cancer: management guidelines and selected literature review. J Clin Oncol. 1987;5(6):969–981.
  • Siegel R, Miller K, Fuchs H, et al. Cancer statistics. CA Cancer J Clin. 2021;71(1):7–33.
  • Warshaw A, Fernández-del Castillo C. Pancreatic carcinoma. The New England Journal of Medicine. 1992;326(7):455–465.
  • Irisawa A, Katanuma A, Itoi T. Otaru consensus on biliary stenting for unresectable distal malignant biliary obstruction. Dig Endosc. 2013;25:52–57.
  • van den Bosch Rp, van der Schelling GP, Klinkenbijl JH, et al., Guidelines for the application of surgery and endoprostheses in the palliation of obstructive jaundice in advanced cancer of the pancreas. Ann Surg. 219(1): 18–24. 1994.
  • Gudjonsson B. Cancer of the pancreas 50 years of surgery. Cancer. 1987;60(9):2284–2303.
  • Sarr MG, Cameron JL. Surgical palliation of unresectable carcinoma of the pancreas. World J Surg. 1984;8(6):906–918.
  • Smith AC, Dowsett JF, Russell RC, et al. Randomised trial of endoscopic steriting versus surgical bypass in malignant low bileduct obstruction. Lancet. 1994;344(8938):1655–1660.
  • Hamada T, Nakai Y, Isayama H, et al. Antireflux metal stent for biliary obstruction: any benefits? Dig Endosc. 2021;3(3):310–320.
  • Wagh MS. Large-diameter plastic biliary stents for unresectable distal malignant biliary strictures: rehashing the same or rekindling more interest? Endoscopy. 2020;52(6):433–434.
  • Speer AG, Cotton PB, Russell RC, et al., Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet. 1987;2(8550): 57–62.
  • Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2020;52(2):127–149.
  • Boskoski I, Costamagna G. How to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis. Gastroenterology. 2020;158(8):2037–2040.
  • Dumonceau JM, Garcia-Fernandez FJ, Verdun FR, et al. Radiation protection in digestive endoscopy: European Society of Digestive Endoscopy (ESGE) guideline. Endoscopy. 2012;44(4):408–421.
  • Beilenhoff U, Biering H, Blum R, et al. Reprocessing of flexible endoscopes and endoscopic accessories used in gastrointestinal endoscopy: position statement of the European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology Nurses and Associates (ESGENA) - Update 2018. Endoscopy. 2018;50(12):1205–1234.
  • Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc. 1998;48(1):1–10.
  • Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335(13):909–918.
  • Cheng CL, Sherman S, Watkins JL, et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol. 2006;101(1):139–147.
  • Kochar B, Akshintala VS, Afghani E, et al. Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointest Endosc. 2015;81(1):143–149.
  • Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001;54(4):425–434.
  • Mutneja HR, Vohra I, Go A, et al. Temporal trends and mortality of post-ERCP pancreatitis in the United States: a nationwide analysis. Endoscopy. 2021;53(4):357–366.
  • Parekh PJ, Majithia R, Sikka SK, et al. The “scope” of post-ERCP pancreatitis. Mayo Clin Proc. 2017;92(3):434–448.
  • Chen DD, Keswani RN. Is needle knife fistulotomy a shortcut to preventing postendoscopic retrograde pancreatitis? Am J Gastroenterol. 2020;115(4):535–536.
  • Elmunzer BJ, Scheiman JM, Lehman GA, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012;366(15):1414–1422.
  • Singh P, MS AD, Isenberg G, et al. Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials. Gastrointest Endosc. 2004;60(4):544–550.
  • Buxbaum J, Yan A, Yeh K, et al. Aggressive hydration with lactated Ringer’s solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography. Clin Gastroenterol Hepatol. 2014;12(2):303–307.
  • Tse F, Yuan Y, Moayyedi P, et al. Guide wire-assisted cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy. 2013;45(8):605–618.
  • Pekgöz M. Post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review for prevention and treatment. World J Gastroenterol. 2019;25(29):4019–4042.
  • Dumonceau JM, Tringali A, Papanikolaou IS, et al. Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2017;50(9):910–930. Updated Oct.
  • Patai A, Solymosi N, Mohacsi L, et al. Indomethacin and diclofenac in the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis of prospective controlled trials. Gastrointest Endosc. 2017;85(6):1144–1156.
  • Luo H, Zhao L, Leung J, et al. Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial. Lancet. 2016;387(10035):2293–2301.
  • Williams E, Beckingham I, El Sayed G, et al. Updated guideline on the management of common bile duct stones (CBDS). Gut. 2017;66(5):765–782.
  • Tomoda T, Kato H, Ueki T, et al. Combination of diclofenac and sublingual nitrates is superior to diclofenac alone in preventing pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology. 2019;156(6):1753–1760.
  • Otsuka T, Kawazoe S, Nakashita S, et al. Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial. J Gastroenterol. 2012;47(8):912–917.
  • Park SW, Chung MJ, Oh TG, et al. Intramuscular diclofenac for the prevention of post-ERCP pancreatitis: a randomized trial. Endoscopy. 2015;47(1):33–39.
  • Katsinelos P, Fasoulas K, Paroutoglou G, et al. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial. Endoscopy. 2012;44(1):53–59.
  • Thiruvengadam NR, Forde KA, Ma GK, et al. Rectal indomethacin reduces pancreatitis in high- and low-risk patients undergoing endoscopic retrograde cholangiopancreatography. Gastroenterology. 2016;151(2):288–297.
  • Levenick JM, Gordon SR, Fadden LL, et al. Rectal indomethacin does not prevent post-ERCP pancreatitis in consecutive patients. Gastroenterology. 2016;150(4):911–917.
  • Orabi AI, Wen L, Javed TA, et al. Targeted inhibition of pancreatic acinar cell calcineurin is a novel strategy to prevent post-ERCP pancreatitis. Cell Mol Gastroenterol Hepatol. 2017;3(1):119–128.
  • Choi JH, Kim HJ, Lee BU, et al. Vigorous periprocedural hydration with lactated Ringer’s solution reduces the risk of pancreatitis after retrograde cholangiopancreatography in hospitalized patients. Clin Gastroenterol Hepatol. 2017;15(1):86–92.
  • Mok SRS, Ho HC, Shah P, et al. Lactated Ringer’s solution in combination with rectal indomethacin for prevention of post-ERCP pancreatitis and readmission: a prospective randomized, double-blinded, placebo-controlled trial. Gastrointest Endosc. 2017;85(5):1005–1013.
  • Njei B, McCarty TR, Muniraj T, et al. Comparative effectiveness of pharmacologic and endoscopic interventions for prevention of post-ERCP pancreatitis: a network meta-analysis. Endosc Int Open. 2020;8(1):29–40.
  • Li ZS, Pan X, Zhang WJ, et al. Effect of octreotide administration in the prophylaxis of post-ERCP pancreatitis and hyperamylasemia: a multicenter, placebo-controlled, randomized clinical trial. Am J Gastroenterol. 2007;102(1):46–51.
  • Xia MX, Zhou YF, Zhang M, et al. The influence of fully covered metal stenting on the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis-A large multicenter study. J Gastroenterol Hepatol. 2020;35(12):2256–2263.
  • Yoon WJ, Ryu JK, Yang KY, et al. A comparison of metal and plastic stents for the relief of jaundice in unresectable malignant biliary obstruction in Korea: an emphasis on cost-effectiveness in a country with a low ERCP cost. Gastrointest Endosc. 2009;70(2):284–289.
  • Coté GA, Kumar N, Ansstas M, et al., Risk of post-ERCP pancreatitis with placement of self-expandable metallic stents. Gastrointest Endosc. 2010;72(4): 748–754.
  • Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ Case Rep. 2009;339:b2535.
  • McCormick F, Cvetanovich GL, Kim JM, et al. An assessment of the quality of rotator cuff randomized controlled trials: utilizing the Jadad score and CONSORT criteria. J Shoulder Elbow Surg. 2013;22(9):1180–1185.
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605.
  • Domagk D, Poremba C, Dietl K-H, et al. Endoscopic transpapillary biopsies and intraductal ultrasonography in the diagnostics of bile duct strictures: a prospective study. Gut. 2002;51(2):240–244.
  • Miyazaki M, Ohtsuka M, Miyakawa S, et al. Classification of biliary tract cancers established by the Japanese Society of Hepato-Biliary-Pancreatic Surgery: 3(rd) English edition. J Hepatobiliary Pancreat Sci. 2015;22(3):181–196.
  • Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37(3):383–393.
  • Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
  • Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
  • Latenstein AEJ, Mackay TM, van Huijgevoort NCM, et al. Nationwide practice and outcomes of endoscopic biliary drainage in resectable pancreatic head and periampullary cancer. HPB (Oxford). 2021;23(2):270–278.
  • Sampaziotis F, Elias J, Gelson WTH, et al. A retrospective study assessing fully covered metal stents as first-line management for malignant biliary strictures. Eur J Gastroenterol Hepatol. 2015;27(11):1347–1353.
  • Elwir S, Sharzehi K, Veith J, et al. Biliary stenting in patients with malignant biliary obstruction: comparison of double layer, plastic and metal stents. Dig Dis Sci. 2013;58(7):2088–2092.
  • Cho JH, Yoon YS, Kim EJ, et al. A multicenter prospective randomized controlled trial for preoperative biliary drainage with uncovered metal versus plastic stents for resectable periampullary cancer. J Hepatobiliary Pancreat Sci. 2020;27(10):690–699.
  • Tol JA, van Hooft JE, Timmer R, et al. Metal or plastic stents for preoperative biliary drainage in resectable pancreatic cancer. Gut. 2016;65(12):1981–1987.
  • Gardner TB, Spangler CC, Byanova KL, et al. Cost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic adenocarcinoma in a randomized controlled trial. Gastrointest Endosc. 2016;84(3):460–466.
  • Olsson G, Frozanpor F, Lundell L, et al. Preoperative biliary drainage by plastic or self-expandable metal stents in patients with periampullary tumors: results of a randomized clinical study. Endosc Int Open. 2017;5(9):798–808.
  • Song TJ, Lee JH, Lee SS, et al. Metal versus plastic stents for drainage of malignant biliary obstruction before primary surgical resection. Gastrointest Endosc. 2016;84(5):814–821.
  • Lee HW, Moon JH, Lee YN, et al. Modified non-flared fully covered self-expandable metal stent versus plastic stent for preoperative biliary drainage in patients with resectable malignant biliary obstruction. J Gastroenterol Hepatol. 2019;34(9):1590–1596.
  • Kaassis M, Boyer J, Dumas R, et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc. 2003;57(2):178–182.
  • Moses PL, Alnaamani KM, Barkun AN, et al. Randomized trial in malignant biliary obstruction: plastic vs partially covered metal stents. World J Gastroenterol. 2013;19(46):8638–8646.
  • Soderlund C, Linder S. Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial. Gastrointest Endosc. 2006;63(7):986–995.
  • Katsinelos P, Paikos D, Kountouras J, et al. Tannenbaum and metal stents in the palliative treatment of malignant distal bile duct obstruction: a comparative study of patency and cost effectiveness. Surg Endosc. 2006;20(10):1587–1593.
  • Bernon MM, Shaw J, Burmeister S, et al., Distal malignant biliary obstruction: a prospective randomised trial comparing plastic and uncovered self-expanding metal stents in the palliation of symptomatic jaundice. S Afr J Surg. 2018;56(1): 30–34.
  • Shim CS, Lee YH, Cho YD, et al. Preliminary results of a new covered biliary metal stent for malignant biliary obstruction. Endoscopy. 1998;30(4):345–350.
  • Shamah SP, Chapman CG, Haider H, et al. Partially covered versus uncovered self-expandable metal stents: coating nor diameter affect clinical outcomes. Dig Dis Sci. 2019;64(9):2631–2637.
  • Yokota Y, Fukasawa M, Takano S, et al. Partially covered metal stents have longer patency than uncovered and fully covered metal stents in the management of distal malignant biliary obstruction: a retrospective study. BMC Gastroenterol. 2017;17(1):105.
  • Kawakubo K, Isayama H, Nakai Y, et al. Efficacy and safety of covered self-expandable metal stents for management of distal malignant biliary obstruction due to lymph node metastases. Surg Endosc. 2011;25(9):181–196.
  • Lee JH, Krishna SG, Singh A, et al. Comparison of the utility of covered metal stents versus uncovered metal stents in the management of malignant biliary strictures in 749 patients. Gastrointest Endosc. 2013;78(2):312–324.
  • Nakamura T, Hirai R, Kitagawa M, et al. Treatment of common bile duct obstruction by pancreatic cancer using various stents: single-center experience. Cardiovasc Intervent Radiol. 2002;25(5):373–380.
  • Park DH, Kim MH, Choi JS, et al. Covered versus uncovered wallstent for malignant extrahepatic biliary obstruction: a cohort comparative analysis. Clin Gastroenterol Hepatol. 2006;4(6):790–796.
  • Isayama H, Komatsu Y, Tsujino T, et al. A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction. Gut. 2004;53(5):729–734.
  • Kitano M, Yamashita Y, Tanaka K, et al. Covered self-expandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma: a randomized multicenter trial. Am J Gastroenterol. 2013;108(11):1713–1722.
  • Kullman E, Frozanpor F, Soderlund C, et al. Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc. 2010;72(5):915–923.
  • Telford JJ, Carr-Locke DL, Baron TH, et al. A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc. 2010;72(5):907–914.
  • Elshimi E, Morad W, Elshaarawy O, et al. Optimization of biliary drainage in inoperable distal malignant strictures. World J Gastrointest Endosc. 2020;12(9):285–296.
  • Yang MJ, Kim JH, Yoo BM, et al. Partially covered versus uncovered self-expandable nitinol stents with anti-migration properties for the palliation of malignant distal biliary obstruction: a randomized controlled trial. Scand J Gastroenterol. 2015;50(12):1490–1499.
  • Hu B, T-t W, Wu J, et al. Antireflux stents to reduce the risk of cholangitis in patients with malignant biliary strictures: a randomized trial. Endoscopy. 2014;46(2):120–126.
  • Ung KA, Stotzer PO, Nilsson A, et al. Covered and uncovered self-expandable metallic Hanarostents are equally efficacious in the drainage of extrahepatic malignant strictures. Results of a double-blind randomized study. Scand J Gastroenterol. 2013;48(4):459–465.
  • Seo DW, Sherman S, Dua KS, et al., Covered and uncovered biliary metal stents provide similar relief of biliary obstruction during neoadjuvant therapy in pancreatic cancer: a randomized trial. Gastrointest Endosc. 90(4): 602–612. 2019.
  • Hatzidakis AA, Tsetis D, Chrysou E, et al. Nitinol stents for palliative treatment of malignant obstructive jaundice: should we stent the sphincter of Oddi in every case? Cardiovasc Intervent Radiol. 2001;24(4):245–248.
  • Uchida N, Tsutsui K, Ezaki T, et al. Estimation of the stent placement above the intact sphincter of Oddi against malignant bile duct obstruction. J Gastroenterol. 2005;40(3):291–296.
  • Pedersen FM, Lassen AT, Schaffalitzky de Muckadell OB. Randomized trial of stent placed above and across the sphincter of Oddi in malignant bile duct obstruction. Gastrointest Endosc. 1998;48(6):574–579.
  • Shimizu S, Naitoh I, Nakazawa T, et al. Predictive factors for pancreatitis and cholecystitis in endoscopic covered metal stenting for distal malignant biliary obstruction. J Gastroenterol Hepatol. 2013;28(1):68–72.
  • Artifon ELA, Sakai P, Ishioka S, et al. Endoscopic sphincterotomy before deployment of covered metal stent is associated with greater complication rate: a prospective randomized control trial. J Clin Gastroenterol. 2008;42(7):815–819.
  • Giorgio PD, Luca LD. Comparison of treatment outcomes between biliary plastic stent placements with and without endoscopic sphincterotomy for inoperable malignant common bile duct obstruction. World J Gastroenterol. 2004;10(8):1212–1214.
  • Nakahara K, Okuse C, Suetani K, et al. Covered metal stenting for malignant lower biliary stricture with pancreatic duct obstruction: is endoscopic sphincterotomy needed? Gastroenterol Res Pract. 2013;2013:375613.
  • Nakahara K, Michikawa Y, Morita R, et al. Endoscopic sphincterotomy before fully covered metal stent placement is not required for distal malignant biliary stricture due to a pancreatic head tumor. Gastroenterol Res Pract. 2019;2019:9675347.
  • Hayashi T, Kawakami H, Osanai M, et al., No benefit of endoscopic sphincterotomy before biliary placement of self-expandable metal stents for unresectable pancreatic cancer. Clin Gastroenterol Hepatol. 2015;13(6): 1151–1158.
  • Ferreira LE, Baron TH. Endoscopic stenting for palliation of malignant biliary obstruction. Expert Rev Med Devices. 2010;7(5):681–691.
  • Committee ATA, Pfau PR, Pleskow DK, et al. Pancreatic and biliary stents. Gastrointest Endosc. 2013;77(3):319–327.
  • Moss AC, Morris E, Mac Mathuna P. Palliative biliary stents for obstructing pancreatic carcinoma. Cochrane Database Syst Rev. 2006;2006(2):CD004200.
  • Arguedas MR, Heudebert GH, Stinnett AA, et al. Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysis. Am J Gastroenterol. 2002;97(4):898–904.
  • Yeoh KG, Zimmerman MJ, Cunningham JT, et al. Comparative costs of metal versus plastic biliary stent strategies for malignant obstructive jaundice by decision analysis. Gastrointest Endosc. 1999;49(4 Pt 1):466–471.
  • Cipolletta L, Rotondano G, Marmo R, et al. Endoscopic palliation of malignant obstructive jaundice: an evidence-based review. Dig Liver Dis. 2007;39(4):375–388.
  • Davids PH, Groen AK, Rauws EA, et al. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet. 1992;340(8834–8835):1488–1492.
  • Prat F, Chapat O, Ducot B, et al. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest Endosc. 1998;47(1):1–7.
  • Jang SI, Kim DU, Cho JH, et al. Primary needle-knife fistulotomy versus conventional cannulation method in a high-risk cohort of post-endoscopic retrograde cholangiopancreatography pancreatitis. Am J Gastroenterol. 2020;115(4):616–624.
  • Hashimoto S, Ito K, Koshida S, et al. Risk factors for post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis and stent dysfunction after preoperative biliary drainage in patients with malignant biliary stricture. Intern Med. 2016;55(18):2529–2536.
  • Irving JD, Adam A, Dick R, et al. Gianturco expandable metallic biliary stents: results of a European clinical trial. Radiology. 1989;172(2):321–326.
  • Lee MJ, Mueller PR, Saini S, et al. Occlusion of biliary endoprostheses: presentation and management. Radiology. 1990;176(2):531–534.
  • Born P, Neuhaus H, Rösch T, et al. Initial experience with a new, partially covered Wallstent for malignant biliary obstruction. Endoscopy. 1996;28(8):699–702.
  • Almadi MA, Barkun AN, Martel M. No benefit of covered vs uncovered self-expandable metal stents in patients with malignant distal biliary obstruction: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11(1):27–37.
  • Chen MY, Lin JW, Zhu HP, et al. Covered stents versus uncovered stents for unresectable malignant biliary strictures: a meta-analysis. Biomed Res Int. 2016;2016:6408067.
  • Li J, Li T, Sun P, et al. Covered versus uncovered self-expandable metal stents for managing malignant distal biliary obstruction: a meta-analysis. PLoS One. 2016;11(2):e0149066.
  • Saleem A, Leggett CL, Murad MH, et al. Meta-analysis of randomized trials comparing the patency of covered and uncovered self-expandable metal stents for palliation of distal malignant bile duct obstruction. Gastrointest Endosc. 2011;74(2):321–327.
  • Moole H, Bechtold ML, Cashman M, et al. Covered versus uncovered self-expandable metal stents for malignant biliary strictures: a meta-analysis and systematic review. Indian J Gastroenterol. 2016;35(5):323–330.
  • Kahaleh M, Tokar J, Le T, et al. Removal of self-expandable metallic Wallstents. Gastrointest Endosc. 2004;60(4):640–644.
  • Familiari P, Bulajic M, Mutignani M, et al. Endoscopic removal of malfunctioning biliary self-expandable metallic stents. Gastrointest Endosc. 2005;62(6):903–910.
  • Jo JH, Park BH. Suprapapillary versus transpapillary stent placement for malignant biliary obstruction: which is better? J Vasc Interv Radiol. 2015;26(4):573–582.
  • Okamoto T, Fujioka S, Yanagisawa S, et al. Placement of a metallic stent across the main duodenal papilla may predispose to cholangitis. Gastrointest Endosc. 2006;63(6):792–796.
  • Huang X, Shen L, Jin Y, et al. Comparison of uncovered stent placement across versus above the main duodenal papilla for malignant biliary obstruction. J Vasc Interv Radiol. 2015;26(3):432–437.
  • Kawakubo K, Isayama H, Nakai Y, et al. Risk factors for pancreatitis following transpapillary self-expandable metal stent placement. Surg Endosc. 2012;26(3):771–776.
  • Cosgrove N, Siddiqui AA, Adler DG, et al. A comparison of bilateral side-by-side metal stents deployed above and across the sphincter of oddi in the management of malignant hilar biliary obstruction. J Clin Gastroenterol. 2017;51(6):528–533.
  • Ishiwatari H, Hayashi T, Ono M, et al. Newly designed plastic stent for endoscopic placement above the sphincter of Oddi in patients with malignant hilar biliary obstruction. Dig Endosc. 2013;25:94–99.
  • Kobayashi N, Watanabe S, Hosono K, et al. Endoscopic inside stent placement is suitable as a bridging treatment for preoperative biliary tract cancer. BMC Gastroenterol. 2015;15:8.
  • Ferreira LEVVC, Baron TH. Post-sphincterotomy bleeding: who, what, when, and how. Am J Gastroenterol. 2007;102(12):2850–2858.
  • Kawai K, Akasaka Y, Murakami K, et al. Endoscopic sphincterotomy of the ampulla of Vater. Gastrointest Endosc. 1974;20(4):148–151.
  • Classen M, Demling L. Endoskopische Sphinkterotomie der Papilla Vateri und Steinextraktion aus dem Ductus choledochus. Dtsch Med Wochenschr. 1974;99(11):496–497.
  • Freeman ML. Understanding risk factors and avoiding complications with endoscopic retrograde cholangiopancreatography. Curr Gastroenterol Rep. 2003;5(2):145–153.
  • Sofi A, Nawras A, Alaradi O, et al. Does endoscopic sphincterotomy reduce the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis after biliary stenting? A systematic review and meta-analysis. Dig Endosc. 2016;28(4):394–404.
  • Cui PJ, Yao J, Zhao YJ, et al. Biliary stenting with or without sphincterotomy for malignant biliary obstruction: a meta-analysis. World J Gastroenterol. 2014;20(38):14033–14039.
  • Banerjee N, Hilden K, Baron TH, et al. Endoscopic biliary sphincterotomy is not required for transpapillary SEMS placement for biliary obstruction. Dig Dis Sci. 2011;56(2):591–595.
  • Zhou H, Li L, Zhu F, et al. Endoscopic sphincterotomy associated cholangitis in patients receiving proximal biliary self-expanding metal stents. Hepatobiliary Pancreat Dis Int. 2012;11(6):643–649.
  • Tarnasky PR, Cunningham JT, Hawes RH, et al., Transpapillary stenting of proximal biliary strictures: does biliary sphincterotomy reduce the risk of postprocedure pancreatitis? Gastrointest Endosc. 1997;45(1): 46–51.
  • Tham TC, Lichtenstein DR, Vandervoort J, et al. Pancreatic duct stents for “obstructive type” pain in pancreatic malignancy. Am J Gastroenterol. 2000;95(4):956–960.
  • Oh D, Park DH, Cho MK, et al. Feasibility and safety of a fully covered self-expandable metal stent with antimigration properties for EUS-guided pancreatic duct drainage: early and midterm outcomes (with video). Gastrointest Endosc. 2016;83(2):366–373.
  • Varadarajulu S, Noone T, Hawes RH, et al., Pancreatic duct stent insertion for functional smoldering pancreatitis. Gastrointest Endosc. 2003;58(3): 438–441.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.